Literature DB >> 17885921

Allosteric agonist modulators.

Terry Kenakin1.   

Abstract

This article discusses a model to describe the effects of molecules that bind to a site on the receptor separate from that of the endogenous agonist to actively produce receptor signals (direct agonism). In addition, these molecules also modify the biological responses of the endogenous agonist (either potentiation or antagonism). The effects of such compounds in high-throughput screening assays are described as well as their effects on the dose-response curves to conventional agonists.

Mesh:

Substances:

Year:  2007        PMID: 17885921     DOI: 10.1080/10799890701509000

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  9 in total

Review 1.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 2.  Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.

Authors:  K Fuxe; D Marcellino; D O Borroto-Escuela; M Guescini; V Fernández-Dueñas; S Tanganelli; A Rivera; F Ciruela; L F Agnati
Journal:  CNS Neurosci Ther       Date:  2010-03-16       Impact factor: 5.243

3.  The δ-opioid receptor positive allosteric modulator BMS 986187 is a G-protein-biased allosteric agonist.

Authors:  M Alexander Stanczyk; Kathryn E Livingston; Louise Chang; Zara Y Weinberg; Manojkumar A Puthenveedu; John R Traynor
Journal:  Br J Pharmacol       Date:  2019-04-14       Impact factor: 8.739

Review 4.  Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two-state and operational models.

Authors:  David Roche; Debora Gil; Jesús Giraldo
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

5.  Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40.

Authors:  Jun Lu; Noel Byrne; John Wang; Gerard Bricogne; Frank K Brown; Harry R Chobanian; Steven L Colletti; Jerry Di Salvo; Brande Thomas-Fowlkes; Yan Guo; Dawn L Hall; Jennifer Hadix; Nicholas B Hastings; Jeffrey D Hermes; Thu Ho; Andrew D Howard; Hubert Josien; Maria Kornienko; Kevin J Lumb; Michael W Miller; Sangita B Patel; Barbara Pio; Christopher W Plummer; Bradley S Sherborne; Payal Sheth; Sarah Souza; Srivanya Tummala; Clemens Vonrhein; Maria Webb; Samantha J Allen; Jennifer M Johnston; Adam B Weinglass; Sujata Sharma; Stephen M Soisson
Journal:  Nat Struct Mol Biol       Date:  2017-06-05       Impact factor: 15.369

Review 6.  The origin of allosteric functional modulation: multiple pre-existing pathways.

Authors:  Antonio del Sol; Chung-Jung Tsai; Buyong Ma; Ruth Nussinov
Journal:  Structure       Date:  2009-08-12       Impact factor: 5.006

Review 7.  Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.

Authors:  P Jeffrey Conn; Arthur Christopoulos; Craig W Lindsley
Journal:  Nat Rev Drug Discov       Date:  2009-01       Impact factor: 84.694

Review 8.  Allosteric Modulation of Muscarinic Acetylcholine Receptors.

Authors:  Jan Jakubík; Esam E El-Fakahany
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-30

9.  Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000.

Authors:  Zhan-Guo Gao; Kai Ye; Anikó Göblyös; Adriaan P Ijzerman; Kenneth A Jacobson
Journal:  BMC Pharmacol       Date:  2008-12-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.